BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 2869721)

  • 1. Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients.
    Sohn YJ; Bencini AF; Scaf AH; Kersten UW; Agoston S
    Anesth Analg; 1986 Mar; 65(3):233-9. PubMed ID: 2869721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition and urinary excretion of vecuronium bromide in anesthetized patients with normal renal function or renal failure.
    Bencini AF; Scaf AH; Sohn YJ; Meistelman C; Lienhart A; Kersten UW; Schwarz S; Agoston S
    Anesth Analg; 1986 Mar; 65(3):245-51. PubMed ID: 2869722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuromuscular blocking action and pharmacokinetics of vecuronium bromide in man--a comparison with pancuronium bromide].
    Sugai N; Yajima C; Inada Y; Hashimoto Y; Irimada T; Amaha K; Mihara J; Kaya K; Morikawa S; Iwai S
    Masui; 1985 Jan; 34(1):59-65. PubMed ID: 2860257
    [No Abstract]   [Full Text] [Related]  

  • 4. Does intravenous infusion of nitroglycerin potentiate pancuronium- and vecuronium-induced neuromuscular blockade?
    Schwarz S; Agoston S; Houwertjes MC
    Anesth Analg; 1986 Feb; 65(2):156-60. PubMed ID: 2867718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure:action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat.
    Bowman WC; Rodger IW; Houston J; Marshall RJ; McIndewar I
    Anesthesiology; 1988 Jul; 69(1):57-62. PubMed ID: 2898902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response relationships and neuromuscular blocking effects of vecuronium pancuronium during ketamine anaesthesia.
    Engbaek J; Ording H; Pedersen T; Viby-Mogensen J
    Br J Anaesth; 1984 Sep; 56(9):953-7. PubMed ID: 6147154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of vecuronium and pancuronium in cats with and without ligated renal pedicles.
    Booij LH; Vree TB; Van de Pol F; Crul JF
    Acta Anaesthesiol Belg; 1982; 33(3):157-65. PubMed ID: 6128859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics and pharmacodynamics of vecuronium in children].
    Steinbereithner K; Fitzal S; Schwarz S; Gilly H; Semsroth M; Weindlmayr-Goettel M
    Cah Anesthesiol; 1984; 32(1):5-10. PubMed ID: 6152193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics and pharmacodynamics of vecuronium and pancuronium in anesthetized man].
    Yajima C; Sugai N; Inada Y
    Masui; 1985 Sep; 34(9):1245-51. PubMed ID: 2868137
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia.
    Engbaek J; Ording H; Viby-Mogensen J
    Br J Anaesth; 1983 Jun; 55(6):497-500. PubMed ID: 6134535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.
    Ali HH; Savarese JJ; Basta SJ; Sunder N; Gionfriddo M
    Br J Anaesth; 1983; 55 Suppl 1():107S-111S. PubMed ID: 6134539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of vecuronium and pancuronium in anesthetized children.
    Meistelman C; Agoston S; Kersten UW; Saint-Maurice C; Bencini AF; Loose JP
    Anesth Analg; 1986 Dec; 65(12):1319-23. PubMed ID: 2877596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical use of vecuronium (ORG NC 45) in balanced anesthesia. Comparison with pancuronium.
    Thomas B; Rolly G; Huylenbroeck G; Beerens J
    Acta Anaesthesiol Belg; 1982; 33(3):167-76. PubMed ID: 6128860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC45) and pancuronium in anesthetized humans.
    Cronnelly R; Fisher DM; Miller RD; Gencarelli P; Nguyen-Gruenke L; Castagnoli N
    Anesthesiology; 1983 May; 58(5):405-8. PubMed ID: 6132566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative pharmacokinetics of pipecuronium bromide, pancuronium bromide and vecuronium bromide in anesthetized man].
    Yajima C; Sugai N; Hanaoka K; Numata K; Yamamoto K; Kushida Y; Murakami S; Yamamura H
    Masui; 1990 Jul; 39(7):882-9. PubMed ID: 1976829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of vecuronium requirements for stable mechanical effect: comparison with or without previous succinylcholine administration.
    d'Hollander A; Agoston S; Barvais L; Massaut J; Baurain M
    Anesth Analg; 1985 Mar; 64(3):319-22. PubMed ID: 2858168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacodynamics of vecuronium. A clinical study].
    Krieg N
    Anaesthesist; 1985 Jul; 34(7):340-5. PubMed ID: 2863999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacokinetic explanation for increasing recovery time following larger or repeated doses of nondepolarizing muscle relaxants.
    Fisher DM; Rosen JI
    Anesthesiology; 1986 Sep; 65(3):286-91. PubMed ID: 2875680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparisons of the dose-response and recovery time course of vecuronium and atracurium in anesthetized chinese adult patients.
    Xue FS; Li P; Liao X; Li CW; Xu YC; Liu Y; Liu KP; Sun HT
    Acta Anaesthesiol Taiwan; 2007 Mar; 45(1):9-14. PubMed ID: 17424753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of the muscle relaxant drug Org NC-45 and each of its hydroxy metabolites in dogs.
    Booij LH; Vree TB; Hurkmans F; Reekers-Ketting JJ; Crul JF
    Anaesthesist; 1981 Jul; 30(7):329-33. PubMed ID: 6115592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.